Interestingly, a few studies have shown that sodium benzoate treatment protects dopaminergic neurons and astrocytes in animal models of Parkinson’s disease (PD) by stimulating the transcription of Glial-cell-line-derived neurotrophic factor (GDNF) in astrocytes [108,109]. The gene discussed is GDNF; the disease is Parkinson disease.